Jev you do realise POH first licensed Diclofenac for the Indian market in November 2011. We're now 3.5 years on. Then in April 2013 they signed a supply agreement with Novartis through Themis. That's 2 years ago. As at end of December they announced $117K revenue (up from $80K) the year before. This has and will go nowhere. Yes you are right, it is not company making, far from it.
Voveran TPM vs voltaren, page-5
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.3¢ | 0.2¢ | $16.54K | 5.758M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 59 | 96791453 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 58594028 | 16 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| AVE (ASX) Chart |